New eczema cream shows promise in early trial
NCT ID NCT06891040
First seen Apr 22, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tested a new cream called VC005 on 118 adults with mild to moderate atopic dermatitis (eczema). The goal was to see if it safely reduces eczema symptoms like redness and itching. Participants used the cream or a placebo for a period, and doctors measured changes in their eczema area and severity. The trial is complete, and results will show if VC005 is effective enough for further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese Academy of Medical Sciences Hospital of Skin Disease
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.